130 related articles for article (PubMed ID: 10844114)
1. A novel adenosine analog, AMP579, inhibits neutrophil activation, adherence and neutrophil-mediated injury to coronary vascular endothelium.
Nakamura M; Zhao ZQ; Clark KL; Velez DV; Guyton RA; Vinten-Johansen J
Eur J Pharmacol; 2000 May; 397(1):197-205. PubMed ID: 10844114
[TBL] [Abstract][Full Text] [Related]
2. Comparative study of AMP579 and adenosine in inhibition of neutrophil-mediated vascular and myocardial injury during 24 h of reperfusion.
Budde JM; Velez DA; Zhao Z; Clark KL; Morris CD; Muraki S; Guyton RA; Vinten-Johansen J
Cardiovasc Res; 2000 Aug; 47(2):294-305. PubMed ID: 10946066
[TBL] [Abstract][Full Text] [Related]
3. Isoflurane inhibits neutrophil-endothelium interactions in the coronary circulation: lack of a role for adenosine triphosphate-sensitive potassium channels.
Hu G; Vinten-Johansen J; Salem MR; Zhao ZQ; Crystal GJ
Anesth Analg; 2002 Apr; 94(4):849-56, table of contents. PubMed ID: 11916783
[TBL] [Abstract][Full Text] [Related]
4. The preischemic combination of the sodium-hydrogen exchanger inhibitor cariporide and the adenosine agonist AMP579 acts additively to reduce porcine myocardial infarct size.
Kristo G; Yoshimura Y; Ferraris SP; Jahania SA; Mentzer RM; Lasley RD
J Am Coll Surg; 2004 Oct; 199(4):586-94. PubMed ID: 15454144
[TBL] [Abstract][Full Text] [Related]
5. Adenosine A2-receptor activation inhibits neutrophil-mediated injury to coronary endothelium.
Zhao ZQ; Sato H; Williams MW; Fernandez AZ; Vinten-Johansen J
Am J Physiol; 1996 Oct; 271(4 Pt 2):H1456-64. PubMed ID: 8897940
[TBL] [Abstract][Full Text] [Related]
6. Adenosine A2 receptor activation attenuates reperfusion injury by inhibiting neutrophil accumulation, superoxide generation and coronary endothelial adherence.
Jordan JE; Zhao ZQ; Sato H; Taft S; Vinten-Johansen J
J Pharmacol Exp Ther; 1997 Jan; 280(1):301-9. PubMed ID: 8996210
[TBL] [Abstract][Full Text] [Related]
7. L-Arginine inhibits neutrophil adherence and coronary artery dysfunction.
Sato H; Zhao ZQ; Vinten-Johansen J
Cardiovasc Res; 1996 Jan; 31(1):63-72. PubMed ID: 8849590
[TBL] [Abstract][Full Text] [Related]
8. Activation of A2A adenosine receptors inhibits expression of alpha 4/beta 1 integrin (very late antigen-4) on stimulated human neutrophils.
Sullivan GW; Lee DD; Ross WG; DiVietro JA; Lappas CM; Lawrence MB; Linden J
J Leukoc Biol; 2004 Jan; 75(1):127-34. PubMed ID: 14525968
[TBL] [Abstract][Full Text] [Related]
9. Inhibitory effects of AMP 579, a novel cardioprotective adenosine A1/A2A receptor agonist, on native IKr and cloned HERG current.
Saegusa N; Sato T; Ogura T; Komuro I; Nakaya H
Naunyn Schmiedebergs Arch Pharmacol; 2004 Dec; 370(6):492-9. PubMed ID: 15558241
[TBL] [Abstract][Full Text] [Related]
10. The nondepolarizing, normokalemic cardioplegia formulation adenosine-lidocaine (adenocaine) exerts anti-neutrophil effects by synergistic actions of its components.
Shi W; Jiang R; Dobson GP; Granfeldt A; Vinten-Johansen J
J Thorac Cardiovasc Surg; 2012 May; 143(5):1167-75. PubMed ID: 22079877
[TBL] [Abstract][Full Text] [Related]
11. Multiple receptor subtypes and multiple mechanisms of dilation are involved in vascular network dilation caused by adenosine.
Thengchaisri N; Miriel VA; Rivers RJ
Microvasc Res; 2009 May; 77(3):356-63. PubMed ID: 19323977
[TBL] [Abstract][Full Text] [Related]
12. Stimulation of endothelial adenosine A1 receptors enhances adhesion of neutrophils in the intact guinea pig coronary system.
Zahler S; Becker BF; Raschke P; Gerlach E
Cardiovasc Res; 1994 Sep; 28(9):1366-72. PubMed ID: 7954647
[TBL] [Abstract][Full Text] [Related]
13. A1 and A2A adenosine receptor modulation of alpha 1-adrenoceptor-mediated contractility in human cultured prostatic stromal cells.
Preston A; Frydenberg M; Haynes JM
Br J Pharmacol; 2004 Jan; 141(2):302-10. PubMed ID: 14751869
[TBL] [Abstract][Full Text] [Related]
14. Limitation of myocardial reperfusion injury by AMP579, an adenosine A1/A2A receptor agonist: role of A2A receptor and Erk1/2.
Kis A; Baxter GF; Yellon DM
Cardiovasc Drugs Ther; 2003; 17(5-6):415-25. PubMed ID: 15107596
[TBL] [Abstract][Full Text] [Related]
15. A2A and A3 receptors mediate the adenosine-induced relaxation in spontaneously active possum duodenum in vitro.
Woods CM; Toouli J; Saccone GT
Br J Pharmacol; 2003 Apr; 138(7):1333-9. PubMed ID: 12711634
[TBL] [Abstract][Full Text] [Related]
16. Purinergic modulation of glutamate release under ischemic-like conditions in the hippocampus.
Sperlágh B; Zsilla G; Baranyi M; Illes P; Vizi ES
Neuroscience; 2007 Oct; 149(1):99-111. PubMed ID: 17850981
[TBL] [Abstract][Full Text] [Related]
17. Effects of AMP579 and adenosine on L-type Ca2+ current in isolated rat ventricular myocytes.
Wang X; Wu BW; Wu DM
Acta Pharmacol Sin; 2005 May; 26(5):559-62. PubMed ID: 15842773
[TBL] [Abstract][Full Text] [Related]
18. A(3) adenosine receptor activation attenuates neutrophil function and neutrophil-mediated reperfusion injury.
Jordan JE; Thourani VH; Auchampach JA; Robinson JA; Wang NP; Vinten-Johansen J
Am J Physiol; 1999 Nov; 277(5):H1895-905. PubMed ID: 10564145
[TBL] [Abstract][Full Text] [Related]
19. Increase in the vasorelaxant potency of K(ATP) channel opening drugs by adenosine A(1) and A(2) receptors in the pig coronary artery.
Davie CS; Everitt DE; Standen NB
Eur J Pharmacol; 1999 Oct; 383(2):155-62. PubMed ID: 10585529
[TBL] [Abstract][Full Text] [Related]
20. Stimulation of neutrophil adherence to vascular endothelial cells by histamine and thrombin and its inhibition by PAF antagonists and dexamethasone.
Watanabe M; Yagi M; Omata M; Hirasawa N; Mue S; Tsurufuji S; Ohuchi K
Br J Pharmacol; 1991 Jan; 102(1):239-45. PubMed ID: 2043925
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
